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chromosome 6 end with its var gene and
two riﬁn genes. This event was, in turn,
stabilized by the chromosome 6 var
recombining with a chromosome 13 var.
The apparently unrelated chromosome 6/
13 var recombination is thus seen to be a
consequence of a recombinational cas-
cade initiated by a DSB in chromosome 12.
The implication is that the structure and
functioning of the antigenic variation
system of P. falciparum have evolved
from activated DNA repair pathways. As
Zhang et al. note, any chromosome
break generating free DNA fragments is
recombinogenic, and cascade-type pro-
cesses are always possible. DSB-initiated
adaptive recombinational cascades have
been observed in cancer cells [8] and in
that model for antigenic variation, trypano-
somes [9]. Another recent paper makes
the interesting and somewhat parallel
case that antimalaria drug-induced
metabolic stress increases the rate of
P. falciparum DSBs (here associated with
intragenic DSSs) causing genome dupli-
cations to facilitate drug resistance via tar-
get protein overexpression [10].
The emerging theme, greatly clariﬁed by
the article from Zhang et al., is that the
P. falciparum genome, intragenic as
much as genic, has evolved to respond
to stress by exploiting evolutionarily an-
cient DNA-repair pathways. The position-
ing of a DSB, which mainly occurs
during mitotic DNA replications in host
erythrocytes, is not random but DSS-
determined. Recombination hotspots,
constraining outcomes, have evolved.
Adaptive genomic plasticity underlies the
capacity of P. falciparum to sometimes
stay one step ahead of a very dangerous
host capable of simultaneously cooking it
with fevers, devouring it with phagocytes,
smothering it with antibodies, and poison-
ing it with drugs. During ‘stressful’ DNA
replication rounds, increasing numbers of
DSBs at nonrandom positions initiate
multiple mitotic recombinational cascades
among a vast intraerythrocytic parasite
population to generate recombinant prog-
eny which might succeed in attaining a
new level of ﬁtness, and survive.
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Spotlight
Post-Kala-Azar Dermal
Leishmaniasis as a
Reservoir for Visceral
Leishmaniasis Transmission
Epke A. Le Rutte, 1,2,3,*
Eduard E. Zijlstra, 4 and
Sake J. de Vlas 1
Post-kala-azar dermal leishmania-
sis (PKDL) is a parasitic skin infec-
tion which can occur after visceral
leishmaniasis (VL). Recent xenodi-
agnosis studies (Mondal et al.,
Clin. Infect. Dis., 2018) have uncov-
ered the infectiousness of PKDL.
When including this in a transmis-
sion model, PKDL cases appear as
an important reservoir of infection,
likely frustrating the VL elimination
efforts on the Indian subcontinent.
Kala-azar, commonly known as visceral
leishmaniasis (VL), is a neglected tropical
disease that has been targeted on the
Indian subcontinent (ISC) for elimination
as a public health problem by 2020, that
is, a reduction of incidence to b1 VL case
per 10 000 of the population per year at
(sub)district level. Leishmania donovani
protozoa are transmitted by female sand
ﬂies and infect humans, who mostly re-
main asymptomatic. However, a small
percentage (1–10%) develop symptom-
atic VL, which is fatal if left untreated [1].
After recovering from VL, about 2.5–20%
of patients develop post-kala-azar dermal
leishmaniasis (PKDL), a nonlethal skin
condition that can last for years and ap-
pears in twomain forms: nodular or macu-
lar [2]. The interventions to achieve the
2020 elimination target focus on timely
diagnosis and treatment of VL cases, and
vector control through indoor residual
spraying of insecticide.
A crucial knowledge gap in the transmission
dynamics of VL is the reservoir of infection. It
is largely unknown if, and to what extent,
asymptomatic and PKDL cases contribute
to transmission, as has long been
highlighted by the PKDL Consortium as
one of the key topics for future research
[3]. Infectious PKDL cases could be a long-
lasting source of transmission and thereby
frustrate elimination efforts. We have
recently explored the signiﬁcance of
these unknowns using two mathematical
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Figure 1. Visceral Leishmaniasis (VL) Incidence Curves during Interventions and the Corresponding Change in Relative Contribution to Transmission of
Different Infection and Disease Stages during theWHOStrategy. The precontrol VL incidence (year –2–0) in a high-endemic setting (10/10 000/year) is followed by
5 years of interventions in the WHO active phase (years 0–5) and then 10 years of interventions in the WHO consolidation phase (years 5–15). The dashed lines represent
the incidence curves for which the regular WHO strategy is combined with the post-kala-azar dermal leishmaniasis (PKDL) control strategy (years 0–15). The black
horizontal dashed line depicts the 1/10 000/year target of elimination as a public health problem. In Model E0 only symptomatic individuals with VL and PKDL
contribute to transmission; in Model E1, asymptomatic individuals also contribute to transmission. The early asymptomatic stage represents individuals that are PCR-
positive and negative in the direct agglutination test (DAT); the late asymptomatic stage represents individuals that are PCR-positive and DAT-positive (as ﬁtted to the
KalaNet dataset, India [9]). Late-asymptomatic individuals are considered to be twice as infectious compared with early-asymptomatic individuals [10]. A small percentage
of late-asymptomatic individuals become symptomatic, after which most receive ﬁrst-line treatment. In case of treatment failure, a second-line treatment is administered.
Individuals in the treatment stages are considered half as infectious compared with those in the symptomatic untreated stage [6]. Further information about the models is
presented in [4].
transmission model variants: one with the
main reservoir of infection in symptomatic
cases, that is, both VL and PKDL (Model
E0), and onewith themain reservoir of infec-
tion in asymptomatic individuals (Model E1)
[4]. Both models assume that 2.5% of
treated VL cases develop PKDL (conserva-
tive assumption based on data from India
[5]), and PKDL was assumed to be half as
infectious as VL [6].
Mondal et al. (October 2018) have re-
ported their ﬁndings of the long awaited
xenodiagnosis studies, that is, exposing
sand ﬂies to individuals with different
stages of disease and infection [7]. They
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found that, for 15 VL and 47 PKDL pa-
tients (comprised of 21 patients with nod-
ular and 26 patients with macular PKDL),
nodular PKDL was more likely (86%) and
macular PKDL less likely (35%) to result
in infected sand ﬂies compared with VL
(67%) [7]. When taking into account the
distribution of the different forms of PKDL
in this region, with 48% being macular
and 52% nodular [8], the relative infec-
tiousness of PKDL is 0.9 compared with
VL (1.0), making PKDL cases nearly
equally infectious.
Figure 1 shows the implications of these
new ﬁndings in a typical high-endemic set-
ting (precontrol incidence of 10 VL cases/
10 000/year), using both model variants
now incorporating the empirically based
PKDL infectiousness of 0.9 relative to
that of VL. Clearly, 5 years of intensive
WHO strategy (solid curves) led to a rapid
incidence reduction to about the target of
1/10 000/year, but when the WHO strat-
egy changed to less-intense interventions
after year 5, incidence reductions slowed
down. The relative contribution to trans-
mission of the different infection stages
during the WHO strategy (two panels
above) indicate that the contribution of
PKDL cases to transmission more than
triples for both models after 5 years of
intensive WHO interventions, clearly
highlighting the need for a PKDL control
strategy. When adding a hypothetical
PKDL control strategy (here: preventing
95% of PKDL) to the existing WHO strat-
egy, the elimination target is achieved as
much as 8 years earlier for model E0
(dashed line). Elimination of transmission
(0/10 000/year) will also be achieved sev-
eral years sooner. The relative contribution
of PKDL to transmission, as well as the
impact of a PKDL control strategy, will be
larger in settings where 20% instead of
2.5% of VL cases develop PKDL.
PKDL control is currently not included in
the main intervention programs, and the
options are limited. Straightforward but
operationally difﬁcult strategies could en-
tail active PKDL case-ﬁnding and treat-
ment, long-term follow-up of VL patients,
patient education on the need to report
to the clinic in case of a rash, and educat-
ing community workers on recognizing
PKDL, all requiring the availability of safe
and effective treatment. For the future,
we hope for better VL treatment, including
a vaccine or immunomodulator to avert
any PKDL development.
Obviously, we also eagerly await the out-
comes of ongoing xenodiagnosis studies
on the infectiousness of asymptomatic in-
dividuals to further complete the VL puzzle
(helping us to choose between both model
variants). If the model-estimated infectious-
ness of asymptomatic cases in Model E1 is
true (i.e., 1–2% relative to VL), then several
hundreds of asymptomatic patients need
to be tested in order to identify the few
that lead to infection of sand ﬂies.
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Can We Recommend
Practical Interventions
to Prevent
Neurocysticercosis?
Uffe Christian Braae,1,2
Marshall W. Lightowlers,3,*
and Meritxell Donadeu3,4
The cystiSim model was used to
compare strategies for the control
of Taenia solium. A three-monthly
intervention in pigs for 3 years was
substantially more effective than
biannual treatment for taeniasis in
the human population for 5 years.
The intervention period could be
shortened further by combining
pig and human interventions.
The World Health Organization (WHO) iden-
tiﬁes neurocysticercosis as a neglected trop-
ical disease and has prioritized Taenia
solium as the focus for new control initiatives
[1]. At this time, there is no consensus as to
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